Dr. Reddy's Laboratories
RDY
#1703
Rank
A$18.01 B
Marketcap
A$21.62
Share price
2.62%
Change (1 day)
3.89%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : A$2.79 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are A$2.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31A$1.65 B-8.23%
2022-03-31A$1.80 B8.66%
2021-03-31A$1.65 B-0.74%
2020-03-31A$1.66 B-3.25%
2019-03-31A$1.72 B-12.94%
2018-03-31A$1.98 B2.52%
2017-03-31A$1.93 B24.08%
2016-03-31A$1.55 B-11.15%
2015-03-31A$1.75 B22.46%
2014-03-31A$1.43 B16.34%
2013-03-31A$1.23 B4.77%
2012-03-31A$1.17 B10.49%
2011-03-31A$1.06 B17.21%
2010-03-31A$0.90 B-22.86%
2009-03-31A$1.17 B12.86%
2008-03-31A$1.04 B-18.2%
2007-03-31A$1.27 B-14.12%
2006-03-31A$1.48 B499.68%
2005-03-31A$0.24 B44.41%
2004-03-31A$0.17 B102.89%
2003-03-31A$84.41 M7.16%
2002-03-31A$78.77 M-51.9%
2001-03-31A$0.16 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
A$115.37 B 4,024.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$167.64 B 5,892.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$98.43 B 3,418.74%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
A$102.56 B 3,566.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$46.53 B 1,563.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel